Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
$0 Mln
Revenue (TTM)
$0 Mln
Net Profit (TTM)
$0 Mln
ROE
-3.3 %
ROCE
-- %
P/E Ratio
--
P/B Ratio
0.5
Industry P/E
36.82
EV/EBITDA
-0.6
Div. Yield
0 %
Debt to Equity
0
Book Value
$--
EPS
$--
Face value
--
Shares outstanding
3,784,966
CFO
$-33.86 Mln
EBITDA
$-32.60 Mln
Net Profit
$-62.47 Mln
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
IMAC Holdings Inc (BACK)
| -- | -- | -- | 29.8 | -75.8 | -73.9 | -- |
|
BSE Sensex
| -13.4 | -9.8 | -13.9 | -3.6 | 7.5 | 7.9 | 11.2 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2024
|
2023
|
|---|---|---|
|
IMAC Holdings Inc (BACK)
| -42.3 | -63.2 |
|
S&P Small-Cap 600
| 7.0 | 13.9 |
|
BSE Sensex
| 8.1 | 18.7 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
IMAC Holdings Inc (BACK)
|
0.1 | 0.2 | 0.1 | -12.5 | -5,022.6 | -- | -- | 0.5 |
| 14.0 | 3,186.8 | 3,125.0 | -262.7 | 0.9 | -313.2 | -- | 20.5 | |
| 380.6 | 5,278.0 | 2,530.0 | 265.2 | 14.2 | 25.3 | 20.1 | 5.3 | |
| 54.5 | 2,778.6 | 941.5 | 105.7 | 14.5 | 29.4 | 26.2 | 7.3 | |
| 97.4 | 9,812.1 | 5,935.2 | 566.2 | 18.1 | 25.1 | 17.6 | 3.9 | |
| 19.1 | 4,280.7 | 2,347.6 | 128.4 | 4.5 | 25.2 | 36.8 | 7.9 | |
| 27.5 | 4,285.8 | 5,649.5 | 207.6 | 7.0 | 15.2 | 21.3 | 3.3 | |
| 54.8 | 4,326.1 | 2,040.2 | -18.7 | 5.0 | -1.9 | -- | 4.0 | |
| 15.0 | 3,768.2 | 1,163.6 | 78.0 | 26.1 | 15.4 | 49.1 | 6.2 | |
| 196.6 | 11,646.4 | 5,057.8 | 344.0 | 9.2 | 16.9 | 34.4 | 5.2 |
IMAC Holdings, Inc., through its subsidiary, Ignite Proteomics LLC, provides proteomic product and precision medicine services based on activated protein analysis for the treatment of cancer in the United States. The company offers a reverse phase... protein array (RPPA) platform, which can quantify protein signaling to support oncology clinical treatment decisions and biopharmaceutical drug development. IMAC Holdings, Inc. was founded in 2000 and is based in Franklin, Tennessee. Read more
Chairman & CEO
Mr. Jeffrey S. Ervin M.B.A.
Chairman & CEO
Mr. Jeffrey S. Ervin M.B.A.
Headquarters
Franklin, TN
Website
The share price of IMAC Holdings Inc (BACK) is $0.06 (NASDAQ) as of 02-Apr-2026 10:39 EDT. IMAC Holdings Inc (BACK) has given a return of -75.77% in the last 3 years.
Since, TTM earnings of IMAC Holdings Inc (BACK) is negative, P/E ratio is not available.
The P/B ratio of IMAC Holdings Inc (BACK) is 0.54 times as on 27-Mar-2026, a 84 discount to its peers’ median range of 3.32 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2024
|
-0.20
|
-0.28
|
|
2023
|
-0.27
|
-3.37
|
|
2022
|
-0.01
|
0.05
|
|
2021
|
-2.69
|
1.66
|
|
2020
|
-0.11
|
0.08
|
The 52-week high and low of IMAC Holdings Inc (BACK) are Rs 0.06 and Rs 0.04 as of 03-Apr-2026.
IMAC Holdings Inc (BACK) has a market capitalisation of $ 0 Mln as on 27-Mar-2026. As per SEBI classification, it is a Small Cap company.
Before investing in IMAC Holdings Inc (BACK), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.